ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
T37-061,Aripiprazole (Abilify),CYP2D6,Major – significant result that may require altering this medication,NA
T37-061,Fluoxetine,"CYP2C9CYP2D6",Major – significant result that may require altering this medication,"INCREASED RISK OF SEROTONIN TOXICITY WITH LISDEXAMFETAMINE, INHIBITOR MODERATE: CYP2C19, INHIBITOR STRONG: CYP2D6"
T37-061,Lisdexamfetamine (Vyvanse),CYP2D6,"Minor – result should be considered as may affect medicationresponse",INCREASED RISK OF SEROTONIN TOXICITY WITH FLUOXETINE
T37-061,Melatonin,CYP1A2,Usual prescribing considerations apply,NA
T37-061,Olanzapine,CYP1A2,Usual prescribing considerations apply,NA
T37-061,buprenorphine (Norspan),NA,NO,NA
